,
WHO classification of tumours of soft tissue and bone, pp.77-79, 2013. ,
Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma, Nat Genet, vol.15, pp.95-98, 1997. ,
Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline, Eur J Cancer, vol.51, pp.2604-2608, 2015. ,
Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP), Clin Cancer Res, vol.22, pp.837-846, 2016. ,
,
WHO classification of tumours of soft tissue and bone, pp.77-79, 2013. ,
Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma, Nat Genet, vol.15, pp.95-98, 1997. ,
Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline, Eur J Cancer, vol.51, pp.2604-2608, 2015. ,
Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP), Clin Cancer Res, vol.22, pp.837-846, 2016. ,
Fluorescence in situ hybridization analysis is a helpful test for the diagnosis of dermatofibrosarcoma protuberans, Mod Pathol, vol.28, pp.230-237, 2015. ,
Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies, Genes Chromosomes Cancer, vol.50, pp.2383-2395, 2003. ,
Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment, Genes Chromosomes Cancer, vol.37, pp.1-19, 2003. ,
A Novel Chromosomal Translocation Associated With COL1A2-PDGFB Gene Fusion in Dermatofibrosarcoma Protuberans: PDGF Expression as a New Diagnostic Tool, JAMA Dermatol, vol.151, pp.1330-1337, 2015. ,
Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion, Virchows Arch Int J Pathol, vol.452, pp.689-696, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00320095
Dermatofibrosarcoma Protuberans-Like Tumor With COL1A1 Copy Number Gain in the Absence of t ,
Translocation (2;17) in recurrent dermatofibrosarcoma protuberans, Cancer Genet Cytogenet, vol.75, pp.156-163, 1994. ,
Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR, Am J Surg Pathol, vol.31, pp.1476-1489, 2007. ,
Near-optimal probabilistic RNA-seq quantification, Nat Biotechnol, vol.34, pp.525-527, 2016. ,
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas ,
URL : https://hal.archives-ouvertes.fr/hal-01684775
, Nat Genet, vol.47, pp.1200-1205, 2015.
Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma, Nat Genet, vol.15, pp.95-98, 1997. ,
Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans, Oncogene, vol.17, pp.1313-1319, 1998. ,
The dermatofibrosarcoma protuberansassociated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB, Cancer Res, vol.59, pp.3719-3723, 1999. ,
The collagen family, Cold Spring Harb Perspect Biol, vol.3, p.4978, 2011. ,
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells ,
, Proc Natl Acad Sci U S A, vol.103, pp.690-695, 2006.
Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors, Genes Chromosomes Cancer, vol.47, pp.21-25, 2008. ,
Overexpression of collagen VI ?3 in gastric cancer ,
, Oncol Lett, vol.7, pp.1537-1543, 2014.
Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells, Cancer Cell, vol.3, pp.377-386, 2003. ,
Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics, Oncotarget, vol.6, pp.29929-29946, 2015. ,
Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer, Gut, vol.64, pp.636-645, 2015. ,